464 related articles for article (PubMed ID: 9366575)
1. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin.
Zheng B; Clarke JB; Busby WH; Duan C; Clemmons DR
Endocrinology; 1998 Apr; 139(4):1708-14. PubMed ID: 9528953
[TBL] [Abstract][Full Text] [Related]
3. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
Moralez A; Busby WH; Clemmons D
Endocrinology; 2003 Jun; 144(6):2489-95. PubMed ID: 12746311
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
5. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
[TBL] [Abstract][Full Text] [Related]
6. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I.
Zheng B; Duan C; Clemmons DR
J Biol Chem; 1998 Apr; 273(15):8994-9000. PubMed ID: 9535886
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucose on insulin-like growth factor binding protein-4 proteolysis.
Jacot TA; Clemmons DR
Endocrinology; 1998 Jan; 139(1):44-50. PubMed ID: 9421396
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
9. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
Parker A; Gockerman A; Busby WH; Clemmons DR
Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
[TBL] [Abstract][Full Text] [Related]
10. Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia.
Nichols TC; Busby WH; Merricks E; Sipos J; Rowland M; Sitko K; Clemmons DR
Endocrinology; 2007 Oct; 148(10):5002-10. PubMed ID: 17640990
[TBL] [Abstract][Full Text] [Related]
11. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.
Parker A; Rees C; Clarke J; Busby WH; Clemmons DR
Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.
Rees C; Clemmons DR
J Cell Biochem; 1998 Dec; 71(3):375-81. PubMed ID: 9831074
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
Durham SK; Riggs BL; Conover CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-I.
Grimes RW; Hammond JM
Endocrinology; 1994 Jan; 134(1):337-43. PubMed ID: 7506209
[TBL] [Abstract][Full Text] [Related]
15. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
Durham SK; Kiefer MC; Riggs BL; Conover CA
J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.
Conover CA; Kiefer MC; Zapf J
J Clin Invest; 1993 Mar; 91(3):1129-37. PubMed ID: 7680662
[TBL] [Abstract][Full Text] [Related]
18. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
[TBL] [Abstract][Full Text] [Related]
19. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions.
Nam T; Moralez A; Clemmons D
Endocrinology; 2002 Jan; 143(1):30-6. PubMed ID: 11751588
[TBL] [Abstract][Full Text] [Related]
20. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells.
Xu Q; Li S; Zhao Y; Maures TJ; Yin P; Duan C
Circ Res; 2004 Mar; 94(5):E46-54. PubMed ID: 15001525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
